Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 87266

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 02, 2021
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Teligent Pharma, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-15

D-0338-2021
Recall number
D-0338-2021
Initiated
February 02, 2021
Classification
Class III
Status
Terminated
Recalling firm
Teligent Pharma, Inc.
Quantity
104,784 tubes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Code information

Lot #: 14297, Exp 9/2021; 15372, Exp 3/2022; 15841, Exp 8/2022

Distribution pattern

USA Nationwide

drug · product 2 of 3

Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 50 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-51

D-0339-2021
Recall number
D-0339-2021
Initiated
February 02, 2021
Classification
Class III
Status
Terminated
Recalling firm
Teligent Pharma, Inc.
Quantity
79,416 tubes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Code information

Lot #: 14297, Exp 9/2021; 15757, Exp 6/2022; 15840, Exp 7/2022; 15970, Exp 9/2022; 15993, Exp 9/2022

Distribution pattern

USA Nationwide

drug · product 3 of 3

Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southbridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-15

D-0340-2021
Recall number
D-0340-2021
Initiated
February 02, 2021
Classification
Class III
Status
Terminated
Recalling firm
Teligent Pharma, Inc.
Quantity
N/A

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Code information

Lot #: 15644, Exp 5/2022

Distribution pattern

USA Nationwide